Showing results (1031-1040 of 1,247) with videos related to
Sort By:
Pageof 125
Cardiology in the Young|September 20, 2023
Optimising motor development in the hospitalised infant with CHD: factors contributing to early motor challenges and recommendations for assessment and interventionStefanie C Rogers, Lauren Malik, Jennifer Fogel, et al.The Journal of Infectious Diseases|April 1, 2025
A viro-immunological model to characterize the antiviral effect of molnupiravir in SARS-CoV-2-infected outpatients: implication for treatment durationBach Tran Nguyen, Julie Bertrand, Akosua A Agyeman, et al.Trials|March 3, 2016
Oral steroids for the resolution of otitis media with effusion (OME) in children (OSTRICH): study protocol for a randomised controlled trialCherry-Ann Waldron, Emma Thomas-Jones, Rebecca Cannings-John, et al.Science (New York, N.Y.)|April 6, 2019
The challenge of antimicrobial resistance: What economics can contributeLaurence S J Roope, Richard D Smith, Koen B Pouwels, et al.Infection Control and Hospital Epidemiology|December 30, 1999
Hospital characteristics associated with colonization of water systems by Legionella and risk of nosocomial legionnaires' disease: a cohort study of 15 hospitalsJ L Kool, D Bergmire-Sweat, J C Butler, et al.Diabetes|January 29, 2011
Ongoing beta-cell turnover in adult nonhuman primates is not adaptively increased in streptozotocin-induced diabetesYoshifumi Saisho, Erica Manesso, Alexandra E Butler, et al.Nature Biotechnology|February 12, 2021
A bacterial protease depletes c-MYC and increases survival in mouse models of bladder and colon cancerDaniel S C Butler, Caterina Cafaro, Johannes Putze, et al.BMJ Open|August 25, 2012
Understanding variation in primary medical care: a nine-country qualitative study of clinicians' accounts of the non-clinical factors that shape antibiotic prescribing decisions for lower respiratory tract infectionLucy Brookes-Howell, Kerenza Hood, Lucy Cooper, et al.Leukemia & Lymphoma|February 28, 2015
An open-label, single-arm, phase 1 study to assess biomarker effects, efficacy and safety of ofatumumab in patients with refractory chronic lymphocytic leukemiaWilliam Nigel Patton, Robert Lindeman, Andrew C Butler, et al.Biotechnology for Biofuels and Bioproducts|July 11, 2025
Chelator-mediated Fenton post-treatment enhances methane yield from lignocellulosic residues via microbial community modulationDaniella V Martinez, Jenna Y Schambach, Oleg Davydovich, et al.Pageof 125